Sagespring Wealth Partners LLC Invests $1.46 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sagespring Wealth Partners LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,793 shares of the medical equipment provider's stock, valued at approximately $1,458,000.

A number of other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares in the last quarter. Geode Capital Management LLC grew its position in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after acquiring an additional 243,802 shares during the last quarter. Fisher Asset Management LLC increased its holdings in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Finally, Invesco Ltd. boosted its stake in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Up 0.3 %

Shares of ISRG traded up $1.40 during trading hours on Friday, reaching $482.74. The stock had a trading volume of 1,618,989 shares, compared to its average volume of 1,599,026. The firm has a 50-day moving average of $522.23 and a 200 day moving average of $532.02. The company has a market cap of $171.94 billion, a P/E ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Piper Sandler reiterated an "overweight" rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $611.81.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.